Amgen Abbvie Competitor) Most Prior Most Prior Recent Year Recent Year Year Year $7.842B $8.394B $7.882B $5.687B 59.15B $11.296B $13.324B 13.427B $5.709B $14.339B $596BS-1.006B Net income Cash Flow from Operations Cash Flow from Investing Activities Cash Flow from Financing Activities $-15.767 S-22.49B $18.708B S-14.396B Accounting Policies and Footnotes 1. Which accounting policies have the most significant impact on the financial statements? Contrast the key accounting policies to those of the competitor. (For example, is one LIFO and the other FIFO? Does one use accelerated depreciation and the other straight-line? Are the depreciable lives of their long-term assets significantly different?) What choices in policies has your company made that limit the ability to directly compare the financial position or profitability of the two companies? Would you characterize the accounting policies of your company as aggressive or conservative